Monthly Cost Comparison: Wegovy vs Mounjaro UK Pricing
Is Wegovy or Mounjaro Better for Weight Loss? Understanding Monthly Cost Differences
The choice between Wegovy and Mounjaro often comes down to individual clinical factors and ongoing affordability. Wegovy follows a structured 16-week dose escalation, starting at 0.25mg (£79.99 monthly) and reaching maintenance at 2.4mg (£209.99 monthly). This predictable pricing structure helps patients budget effectively for long-term weight management. Mounjaro has a different dose escalation pattern and pricing schedule, making direct monthly comparisons complex.
Both medications require ongoing commitment, with clinical trials suggesting weight regain when treatment stops. The STEP trials demonstrated that patients regained approximately two-thirds of weight lost within one year of discontinuing Wegovy, highlighting the importance of considering long-term monthly costs. At EverydayMeds, we provide transparent pricing for both options, allowing you and your prescriber to make cost-informed decisions about which treatment may be more suitable.
Wegovy Monthly Cost Breakdown: Is This Better Value Than Mounjaro?
Wegovy's monthly costs increase systematically during the dose escalation phase. Week 1-4 costs £79.99 (0.25mg), weeks 5-8 cost £94.99 (0.5mg), weeks 9-12 cost £99.99 (1mg), and weeks 13-16 cost £139.99 (1.7mg). From week 17 onwards, the maintenance dose of 2.4mg costs £209.99 monthly. New customers benefit from the FIRST40 discount code, while returning customers use DOSE25 to maintain competitive pricing throughout their treatment journey.
Annual maintenance cost for Wegovy totals approximately £2,520 at the 2.4mg dose, making budgeting straightforward for long-term treatment planning. Our bundle options, such as the Ultimate Stability Trio providing three months of 2.4mg maintenance supply for £649.99, offer convenience through reduced ordering frequency and Reliable Supply. This transparent pricing structure allows direct comparison with Mounjaro's costs when determining which medication offers better value for your specific circumstances.
Clinical Evidence: Which is Better - Wegovy or Mounjaro for Weight Loss?
Wegovy's clinical evidence comes primarily from the STEP trial programme. In clinical trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP 5 trial demonstrated sustained weight loss of approximately 15.2% at two years, while the SELECT trial showed a 20% reduction in major cardiovascular events.
Mounjaro's evidence comes from different trial designs with different patient populations, making direct percentage comparisons inappropriate. Both medications have demonstrated efficacy in their respective clinical programmes, but individual responses vary significantly. Your prescriber can help evaluate which medication's clinical profile and monthly cost structure align better with your weight management goals and budget.
How Wegovy Works: Understanding Why This Might Be Better for Your Weight Loss Goals
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural fullness hormone produced in your intestines. This mechanism reduces appetite by acting on brain appetite centres, promoting feelings of fullness after smaller meals. Unlike Mounjaro's dual GIP and GLP-1 receptor action, Wegovy targets the single GLP-1 pathway, which some patients may respond to differently. The once-weekly injection using Novo Nordisk's FlexTouch pen provides consistent medication levels throughout the week. Clinical studies suggest this mechanism may also reduce food cravings, supporting long-term dietary changes essential for sustained weight management alongside the medication's effects.
Ordering Process: Getting Wegovy vs Mounjaro - Which is Better for Convenience?
EverydayMeds streamlines access to both Wegovy and Mounjaro through our standardised ordering process. The three-minute online clinical assessment covers medical history, current medications, and weight management goals relevant to both treatments. Our prescribers typically complete reviews within three working days, or 24 hours with express service, regardless of which medication you're considering. Once approved, next-day cold-chain delivery ensures both Wegovy and Mounjaro arrive in optimal condition. Our GPhC #9012878 registered pharmacy status ensures both medications meet UK regulatory standards. The identical ordering process means convenience factors won't influence your choice between these prescription-only medicines.
Storage and Practical Considerations: Wegovy vs Mounjaro Comparison
Wegovy offers a storage advantage with six weeks room temperature tolerance (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both require refrigeration at 2-8°C before first use, but Wegovy's extended room temperature stability provides greater flexibility for travel and daily life. The FlexTouch pen design is pre-filled and disposable, eliminating dose preparation complexity. Wegovy's dose escalation follows a fixed 16-week schedule, making treatment planning straightforward compared to Mounjaro's different escalation pattern. This storage advantage and predictable dosing schedule may influence your decision when weighing practical factors alongside clinical and cost considerations.
Long-term Monthly Budgeting: Is Wegovy or Mounjaro Better Financial Planning?
Wegovy's structured pricing makes annual budgeting straightforward, with total first-year costs including dose escalation approximately £2,040, and subsequent years at £2,520 for maintenance dosing. The DOSE25 discount code ensures returning customers maintain competitive pricing throughout long-term treatment. Bundle purchasing through options like our three-month Ultimate Stability Trio reduces ordering frequency and provides supply security during potential shortages.
Weight management requires long-term commitment, and Wegovy's transparent monthly costs facilitate better financial planning compared to medications with variable pricing structures. Many patients budget for 12-18 months initially, allowing time to establish sustainable lifestyle changes alongside medication support. Our flexible purchasing options, from individual pens to three-month bundles, accommodate different budgeting preferences and financial circumstances.
Making Your Choice: Wegovy vs Mounjaro Cost and Clinical Consultation
Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which is right for your specific circumstances. Cost considerations must balance against clinical factors, individual response patterns, and lifestyle compatibility. Some patients respond better to Wegovy's single-pathway GLP-1 mechanism, while others may benefit from Mounjaro's dual-receptor approach. Monthly cost differences should be weighed against potential effectiveness variations and practical factors like storage requirements. Our clinical team reviews each assessment individually, considering medical history, concurrent medications, and treatment goals. Remember that both medications work alongside reduced-calorie diet and increased physical activity - the most effective choice is the one you can afford consistently while maintaining the necessary lifestyle changes. Start your assessment today using discount code FIRST40 for new customers at https://everydaymeds.co.uk/collections/wegovy, where our GPhC #9012878 registered pharmacy ensures safe, legal access to genuine medications.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
